Literature DB >> 16616787

Attentional performance of C57BL/6 and DBA/2 mice in the 5-choice serial reaction time task.

S Patel1, I P Stolerman, P Asherson, F Sluyter.   

Abstract

C57BL/6 and DBA/2 were compared in the 5-choice serial reaction time task for differences in performance related to attention and impulsivity. The goal was to examine behavioural processes in mice that may relate to ADHD in humans. Groups of male mice were trained to nose-poke in response to a stimulus light presented randomly in one of five holes; correct responses were reinforced with food. During training the stimulus duration (SD) was reduced progressively from 60 to 0.5s. The C57BL/6 and DBA/2 mice did not differ during early stages of training when attentional demands were low (SD of 60, 10 or 5s). As task demands increased, strain differences emerged; C57BL/6 mice were more accurate than DBA/2 mice with stimuli of 2, 1 and 0.5s. DBA/2 mice also made more anticipatory (impulsive) responses during inter-trial intervals than C57BL/6 mice at SD of 5, 2, 1 and 0.5s. The ability to carry out the task was present in both strains of mice but they differed significantly in the levels of performance that were achieved. It is argued that the differences in accuracy and anticipatory responding were closely related and that the primary difference between the strains may be in impulsivity.

Entities:  

Mesh:

Year:  2006        PMID: 16616787     DOI: 10.1016/j.bbr.2006.02.019

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  31 in total

1.  Pregabalin- and topiramate-mediated regulation of cognitive and motor impulsivity in DBA/2 mice.

Authors:  Francisco Navarrete; José M Pérez-Ortiz; Jorge Manzanares
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

Review 2.  Mouse models for studying genetic influences on factors determining smoking cessation success in humans.

Authors:  F Scott Hall; Athina Markou; Edward D Levin; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2012-02       Impact factor: 5.691

3.  Risk taking and impulsive behaviour: fundamental discoveries, theoretical perspectives and clinical implications.

Authors:  Anthony R Isles; Catharine A Winstanley; Trevor Humby
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-02-18       Impact factor: 6.237

4.  Role of prefrontal 5-HT in the strain-dependent variation in sign-tracking behavior of C57BL/6 and DBA/2 mice.

Authors:  P Campus; A Accoto; M Maiolati; C Latagliata; C Orsini
Journal:  Psychopharmacology (Berl)       Date:  2016-01-04       Impact factor: 4.530

5.  Mouse strain differences in punished ethanol self-administration.

Authors:  Lindsay R Halladay; Adrina Kocharian; Andrew Holmes
Journal:  Alcohol       Date:  2016-10-18       Impact factor: 2.405

6.  Acetylcholine receptor and behavioral deficits in mice lacking apolipoprotein E.

Authors:  Jessica A Siegel; Theodore S Benice; Peter Van Meer; Byung S Park; Jacob Raber
Journal:  Neurobiol Aging       Date:  2009-01-28       Impact factor: 4.673

Review 7.  Consideration of species differences in developing novel molecules as cognition enhancers.

Authors:  Jared W Young; J David Jentsch; Timothy J Bussey; Tanya L Wallace; Daniel M Hutcheson
Journal:  Neurosci Biobehav Rev       Date:  2012-10-12       Impact factor: 8.989

8.  Performance of C57BL/6J and DBA/2J mice on a touchscreen-based attentional set-shifting task.

Authors:  Price E Dickson; Michele A Calton; Guy Mittleman
Journal:  Behav Brain Res       Date:  2013-12-18       Impact factor: 3.332

Review 9.  Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.

Authors:  Jared W Young; Susan B Powell; Victoria Risbrough; Hugh M Marston; Mark A Geyer
Journal:  Pharmacol Ther       Date:  2009-03-06       Impact factor: 12.310

10.  The 5-choice continuous performance test: evidence for a translational test of vigilance for mice.

Authors:  Jared W Young; Gregory A Light; Hugh M Marston; Richard Sharp; Mark A Geyer
Journal:  PLoS One       Date:  2009-01-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.